Rg1 appears to regulate the occurrence and development of NASH inflammation through miR-375-3p and ATG2B in vitro and in vivo, and is regulated by PTEN-AKT pathway. The gene discussed is ATG2B; the disease is metabolic dysfunction-associated steatohepatitis.